Join
Live feed
·
INSIDERFilingvia Quantisnow
Cabaletta Bio Inc. logo

Director Simon Mark bought $25,261 worth of shares (11,061 units at $2.28), increasing direct ownership by 8% to 147,205 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CABA (Cabaletta Bio Inc.) and more on Quantisnow.